Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Noah KojimaKatherine AdamsWesley H SelfManjusha GaglaniTresa McNealShekhar GhamandeJay S SteingrubNathan I ShapiroAbhijit DuggalLaurence W BusseMatthew E PrekkerIthan D PeltanSamuel M BrownDavid N HagerHarith AliMichelle N GongAmira MohamedMatthew C ExlineAkram KhanJennifer G WilsonNida QadirSteven Y ChangAdit A GindeCori A WithersNicholas M MohrChristopher MallowEmily T MartinAdam S LauringNicholas J JohnsonJonathan D CaseyWilliam B StubblefieldKevin W GibbsJennie H KwonAdrienne BaughmanJames D ChappellKimberly W HartIan D JonesJillian P RhoadsSydney A SwanKelsey N WomackYuwei ZhuDiya SurieMeredith L McMorrowManish M PatelMark W Tenfordenull nullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Compared to adults hospitalized during early COVID-19 variant periods, those hospitalized during Omicron-variant COVID-19 were older, had multiple co-morbidities, were more likely to be vaccinated, and less likely to experience severe respiratory disease, systemic inflammation, coagulopathy, and death.